Qube Research & Technologies LTD Amgen Inc Call Options Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $19.2 Million - $21 Million	62,200 Added 296.19%	83,200 $26.8 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $1.94 Million - $2.36 Million	-7,400 Reduced 26.06%	21,000 $6.56 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $349,531 - $421,928	-1,300 Reduced 4.38%	28,400 $8.07 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $6.93 Million - $7.82 Million	27,100 Added 1042.31%	29,700 $8.55 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $568,490 - $705,796	2,600 New	2,600 $698,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.